Liu, Dan <br/><br/>
The novel α-glucan YCP improves the survival rates and symptoms in septic mice by regulating myeloid-derived suppressor cells.  [electronic resource] 

 -  Acta pharmacologica Sinica  Sep 2017 
 - 1269-1281 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1745-7254 
<br/><br/><label>Standard No.: </label>10.1038/aps.2017.27  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Ascomycota--chemistry<br/>Cell Proliferation--drug effects<br/>Cell Survival--drug effects<br/>Cells, Cultured<br/>Disease Models, Animal<br/>Dose-Response Relationship, Drug<br/>Male<br/>Mice<br/>Mice, Inbred C57BL<br/>Myeloid-Derived Suppressor Cells--drug effects<br/>Polysaccharides--chemistry<br/>Shock, Septic--drug therapy<br/>Structure-Activity Relationship<br/>Survival Rate<br/>Syndrome